Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Episode 20: Ocriplasmin Postmarketing Data

  Channels: Retina | Posted 9/29/2014

Moderators Thomas Albini, MD, and Jonathan L. Prenner, MD, discuss with Sumit P. Shah, MD, a study on real-world data of clinical use of ocriplasmin. Dr. Shah explains his motivation to start a study after the drug received FDA approval in 2012. He elaborates on the data accumulated from the study and addresses side effects associated with ocriplasmin use.


28 / 47 Series: Retina Today Journal Club


More Videos in this Series